Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for IDYA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 828.96M
March 31, 2026 671.20M
December 31, 2025 639.39M
September 30, 2025 786.89M
June 30, 2025 669.74M
March 31, 2025 692.51M
December 31, 2024 676.32M
September 30, 2024 920.03M
June 30, 2024 701.66M
March 31, 2024 698.77M
December 31, 2023 525.11M
September 30, 2023 468.75M
June 30, 2023 493.72M
March 31, 2023 339.47M
December 31, 2022 364.83M
September 30, 2022 386.24M
Date Value
June 30, 2022 268.62M
March 31, 2022 252.60M
December 31, 2021 246.77M
September 30, 2021 264.55M
June 30, 2021 274.18M
March 31, 2021 302.32M
December 31, 2020 283.58M
September 30, 2020 278.68M
June 30, 2020 170.41M
March 31, 2020 87.86M
December 31, 2019 98.96M
September 30, 2019 109.36M
June 30, 2019 120.16M
March 31, 2019 79.02M
December 31, 2018 89.96M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Xencor, Inc. 456.45M
UroGen Pharma Ltd. 109.30M
MeiraGTx Holdings Plc 143.17M
ACADIA Pharmaceuticals, Inc. 956.47M
Alnylam Pharmaceuticals, Inc. 3.308B